$RDI

Reading International Inc: Reading International Reports Second Quarter 2026 Results

Reading International, Inc. (NASDAQ: RDI) reported Q2 2026 results. Total revenues rose 11% to $66.9 million, operating income increased to $7.5 million, and EBITDA grew to $11.3 million. Net income was $2.3 million versus a $2.8 million loss in Q2 2025. The company cited cinema revenue growth and currency effects.

Original reporting
Published Aug 14, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RDI
Bullish
medium confidence
Mentioned
$RDI
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$RDIBullishMed
01

Why it matters

The release provides a full Q2 and six-month financial snapshot plus management commentary on cinema momentum, cost reductions, and ongoing real-estate monetization plans.

02

Market read

Traders can reassess near-term expectations based on the magnitude of operating income and EBITDA improvement, plus management’s stated momentum into Q3.

03

What to watch

Investors may discount the results if future quarters depend on a strong movie slate and if theater attendance trends (noted U.S. attendance decline) reassert pressure.

Relevance 8/10Novelty 7/10Timing: earnings release dated Aug. 14, 2026, ahead of the Aug. 18 webcast

Background

Reading International is a diversified cinema and real estate operator with operations in the U.S., Australia, and New Zealand.

Company-level read

Ticker impact

$RDIBullishMedium confidence
Context

Reading International reported Q2 2026 results, with total revenues up to $66.9M and operating income up to $7.5M versus Q2 2025.

Expected impact

Likely positive bias for the next session and into the earnings follow-through, assuming the market focuses on operating income and cinema revenue strength.

Evidence & confidence

The article provides multiple concrete Q2 datapoints (revenue, operating income, EBITDA, EPS, net income) and management commentary on continued momentum into Q3, which are direct inputs to valuation and forward expectations.

Market effects

Highlights operating leverage in cinema exhibition and the role of currency moves and selective asset monetization in REIT-like real estate cash generation.

Emphasizes Australia and New Zealand revenue exposure, with AUD strength cited as a positive driver of U.S.-reported results.

Limited broader market impact; primarily company-specific read-through to cinema box office performance and regional FX sensitivity.

Counterpoint

The improvement may be partly mix and FX-driven, and the company is still pursuing liquidity via asset sales, which can mask underlying cash generation durability.

Key entities

  • Reading International, Inc.

    NASDAQ-listed cinema and real estate company reporting Q2 2026 results.

  • Ellen Cotter

    President and CEO quoted on Q2 performance and outlook.

Related articles

$JETBFMed

Global Crossing Airlines Group Inc. (JETBF): Results of Operations and Financial Condition

Global Crossing Airlines Group Inc. (JETBF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jetmf-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Global Crossing Airlines Reports Second Quarter 2026 Financial Results Improved Fleet Efficiency and Aircraft Utilization Drive EBITDA Growth Despite Fewer Net Available Aircraft Advances Fleet Modernization Initiative with

$PAVMMed

PAVmed Inc. (PAVM): Results of Operations and Financial Condition

PAVmed Inc. (PAVM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results Veris Health accelerated its commercial engagement with OSU-The James Veris Health implantable physiological monitor achieved development milestones towards

$AAOIHighAI 9/10

Why is Applied Optoelectronics stock surging today?

Applied Optoelectronics (AAOI) shares rose 17.1% to $152.35 after Q2 2026 results. Revenue was $191.9M vs $102.9M a year earlier, and non-GAAP EPS was $0.06 vs $0.01–$0.02 expected. Q3 revenue guidance was $255M–$290M, with a mid-2027 monthly data center revenue target near $471M. A reported draft U.S. policy to restrict imports of Chinese optical transceivers also supported the move.

$SINDMed

Sinda Ltd. (SIND): Results of Operations and Financial Condition

Sinda Ltd. (SIND) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ef20080100_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Sinda Ltd. Reports Second Quarter 2026 Financial Results and Provides Operational Update Raised Total Gross Proceeds of ~$331 million via IPO and Fresnillo Concurrent Placement Completed 60,810-Meter Phase 1 Surface Drilli